UVE director granted 3,414 restricted shares

Gordon Marlene reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Gordon Marlene reported acquisition or exercise transactions in this Form 4 filing.

UNIVERSAL INSURANCE HOLDINGS, INC. director Marlene Gordon received a grant of 3,414 shares of common stock as an equity award. These are restricted shares that will vest on the earlier of June 11, 2027 or the date of the next annual meeting that is at least 50 weeks after the immediately preceding year's annual meeting. Following this grant, Gordon directly holds 28,475 common shares.

Insider Trade Summary

Grant/Award: 3,414 shares

Grant/Award 1 txn

Insider Gordon Marlene

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,414	$0.00	$0.00

Holdings After Transaction: Common Stock — 28,475 shares (Direct)

Footnotes (1)

1. F1. These restricted shares will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting that is at least 50 weeks after the immediately preceding year's annual meeting.

Key Figures

Restricted shares granted: 3,414 shares Shares held after transaction: 28,475 shares Transaction price per share: $0.0000 per share +1 more

4 metrics

Restricted shares granted 3,414 shares Equity award to director on June 11, 2026

Shares held after transaction 28,475 shares Director direct ownership following grant

Transaction price per share $0.0000 per share Indicates grant/award, not market purchase

Vesting date trigger June 11, 2027 Latest vesting date for restricted shares

Key Terms

restricted shares, annual meeting, grant, award, or other acquisition

3 terms

restricted shares financial

"These restricted shares will vest on the earlier of (i) June 11, 2027..."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

annual meeting financial

"...or (ii) the date of the next annual meeting that is at least 50 weeks..."

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did UVE director Marlene Gordon report on this Form 4?

Director Marlene Gordon reported receiving a grant of 3,414 shares of Universal Insurance Holdings common stock. The award was made at no cash cost per share, reflecting stock-based compensation rather than an open-market purchase or sale.

How many UVE shares does Marlene Gordon hold after this reported grant?

After the reported equity grant, Marlene Gordon directly holds 28,475 shares of Universal Insurance Holdings common stock. This total includes the newly granted restricted shares and provides context for the size of the award relative to her disclosed holdings.

When do Marlene Gordon’s newly granted UVE restricted shares vest?

The restricted shares vest on the earlier of June 11, 2027 or the date of the next annual meeting that occurs at least 50 weeks after the immediately preceding year's annual meeting. This structure ties vesting both to time and the company’s shareholder meeting schedule.

Was the UVE insider transaction an open-market buy or sell of shares?

No, the Form 4 shows a grant of 3,414 restricted shares coded as an award acquisition, not an open-market purchase or sale. The transaction price per share is reported as 0.0000, indicating stock-based compensation rather than a cash transaction.

What does transaction code 'A' mean in Marlene Gordon’s UVE Form 4?

Transaction code "A" represents a grant, award, or other acquisition of securities. In this case, it reflects 3,414 restricted shares of Universal Insurance Holdings common stock granted to director Marlene Gordon as compensation, rather than shares bought in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 05:53 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gordon Marlene

(Last) (First) (Middle)

1110 W. COMMERCIAL BLVD.

SUITE 100

(Street)

FORT LAUDERDALE FLORIDA 33309

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL INSURANCE HOLDINGS, INC. [ UVE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		A		3,414(1)	A	$0	28,475	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These restricted shares will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting that is at least 50 weeks after the immediately preceding year's annual meeting.

Remarks:

	/s/ Marlene Gordon	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)